decreased aerobic running capacity_Tg(CMV-IGL@AL080)55Dcs/0

http://metadb.riken.jp/0003061IFVBTgCMVIGLAL08055Dcs0TgCMVIGLAL08055Dcs

decreased aerobic running capacity_Tg(CMV-IGL@AL080)55Dcs/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 55, David C Seldin
  http://metadb.riken.jp/db/mgi_rdf/MGI:5318683

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(CMV-IGL@AL080)55Dcs/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CMV-IGL@AL080)55Dcs

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased aerobic running capacity
  http://purl.obolibrary.org/obo/MP_0003061

文献

http://purl.org/net/cito/citesAsAuthority

• Jennifer Ellis. Ward, et.al., Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis., Blood, 2011, 118
  http://rdf.ncbi.nlm.nih.gov/pubmed/21998211